Text

Apos® Study Reveals: 87% of Apos®-Treated Patients With Knee OA Did Not Pursue Further Surgical Treatment at 5 Years

Apos® Study Reveals 87% of Apos® treated patients who suffer from knee osteoarthritis did not need to pursue further surgical treatment at 5 years.   

AposHealth® is proud to announce the acceptance of a research article in the Journal of Musculoskeletal Research. This study conducted by Montefiore Health System demonstrates a remarkable 87% of patients with knee osteoarthritis treated with Apos® did not need to pursue further surgical procedures at 5 years.

This research solidifies Apos® track record of success in treating knee osteoarthritis. The consistent results from two other studies reveal an impressive 89% avoidance rate in TKR over six years and an 81% avoidance of TKR at the five-year mark. These findings underscore the effectiveness of Apos® in providing long-term relief for patients with knee osteoarthritis.

As the healthcare landscape continues to evolve, Apos® non-surgical solution emerges as a transformative force, providing a viable and sustainable alternative for patients and presenting a compelling case for payors and employer groups seeking innovative, cost-effective solutions for musculoskeletal care.

For those interested in accessing the study, the original publication can be found here:

https://www.worldscientific.com/doi/epdf/10.1142/S0218957723500203

Don’t let knee or lower back pain hold you back any longer.

Many insurances cover Apos completely.

Schedule a quick call with our experts to learn if you qualify and how Apos® can help.

In case your healthcare coverage is not listed, please choose "Other."
By providing your phone number and email, you agree to be contacted by our team via a call, SMS and email messages. To unsubscribe anytime click the unsubscribe link in our emails or by replying STOP to our SMS messages.

Before you go…

Don’t miss out on this must-read e-book
Your knees and back will thank you!.

Check out our e-book of Myths & Facts About Knee & Back Pain.

Enter your email to start reading